核酸検査の世界市場 - 成長、将来展望、競合分析（2022年～2030年）

世界の核酸検査の市場は、研究機関や製薬会社による遺伝子工学の広範な採用、診断技術の技術的進歩、感覚技術による迅速な分析、分子診断検査に関する意識の高まりなどによって促進されています。

当レポートでは、世界の核酸検査市場を調査しており、市場の概要、市場分析、技術別・用途別・地域別の分析、競合情勢、および企業プロファイルなど包括的な情報を提供しています。

目次

第1章 序文

• レポートの説明
  • レポートの目的
  • 対象者
  • 主な製品
• 市場セグメンテーション
• 調査手法
  • フェーズI - 2次調査
  • フェーズII - 1次調査
  • フェーズIII - 専門家による審査
  • 前提条件
  • 採用されたアプローチ

第2章 エグゼクティブサマリー

• 市場スナップショット：世界の核酸検査市場
• 世界の核酸検査市場、技術別、2021年
• 世界の核酸検査市場、用途別、2021年
• 世界の核酸検査市場、地域別、2021年
• 魅力的な投資提案、地域別、2021年

第3章 核酸検査市場：競合分析

• 主要な核酸検査市場ベンダーの市場ポジショニング
• 核酸検査市場のベンダーが採用する戦略
• 主要な業界戦略
• ティア分析、2021年対2030年

第4章 核酸検査市場：マクロ分析と市場力学

• イントロダクション
• 世界の核酸検査市場金額（2020年～2030年）
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析

第5章 核酸検査市場：技術別（2020年～2030年）

• 市場概要
• 成長と収益分析：2021年対2030年
• 市場セグメンテーション
  • ポリメラーゼ連鎖反応（PCR）
  • ストランド変位増幅（SDA）
  • トロカールリガーゼ連鎖反応（LCR）
  • 転写増幅法（TMA）
  • その他

第6章 核酸検査市場：用途別（2020年～2030年）

• 市場概要
• 成長と収益分析：2021年対2030年
• 市場セグメンテーション
  • 感染症
  • 遺伝性疾患
  • がん
  • フォレンジックテスト
  • その他

第7章 北米の核酸検査市場（2020年～2030年）

• 市場概要
• 核酸検査市場：技術別（2020年～2030年）
• 核酸検査市場：用途別（2020年～2030年）
• 核酸検査市場：地域別（2020年～2030年）
  • 北米

第8章 英国・欧州連合の核酸検査市場（2020年～2030年）

• 市場概要
• 核酸検査市場：技術別（2020年～2030年）
• 核酸検査市場：用途別（2020年～2030年）
• 核酸検査市場：地域別（2020年～2030年）
  • 英国・欧州連合

第9章 アジア太平洋の核酸検査市場（2020年～2030年）

• 市場概要
• 核酸検査市場：技術別（2020年～2030年）
• 核酸検査市場：用途別（2020年～2030年）
• 核酸検査市場：地域別（2020年～2030年）
  • アジア太平洋

第10章 ラテンアメリカの核酸検査市場（2020年～2030年）

• 市場概要
• 核酸検査市場：技術別（2020年～2030年）
• 核酸検査市場：用途別（2020年～2030年）
• 核酸検査市場：地域別（2020年～2030年）
  • ラテンアメリカ

第11章 中東・アフリカの核酸検査市場（2020年～2030年）

• 市場概要
• 核酸検査市場：技術別（2020年～2030年）
• 核酸検査市場：用途別（2020年～2030年）
• 核酸検査市場：地域別（2020年～2030年）
  • 中東・アフリカ

第12章 企業プロファイル

• Automatic Liquid Packaging Solutions, Llc.
• Catalent, Inc.
• HealthStar, Inc.
• Hunan Chinasun Pharmaceutical Machinery Co., Ltd.
• Mahanagar Engineering Pvt. Ltd.
• Pharmapack Co., Ltd.
• Rommelag Inc.
• Shanghai Pharmaceutical Machinery Co., Ltd.
• Shanghai Sunway International Trade Co., Ltd.
• Truking Technology Ltd.
• Unither
• Weiler Engineering, Inc.

List of Tables

• TABLE 1 Global Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 2 Global Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 3 North America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 4 North America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 5 U.S. Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 6 U.S. Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 7 Canada Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 8 Canada Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 9 Rest of North America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 10 Rest of North America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 11 UK and European Union Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 12 UK and European Union Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 13 UK Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 14 UK Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 15 Germany Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 16 Germany Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 17 Spain Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 18 Spain Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 19 Italy Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 20 Italy Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 21 France Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 22 France Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 23 Rest of Europe Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 24 Rest of Europe Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 25 Asia Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 26 Asia Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 27 China Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 28 China Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 29 Japan Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 30 Japan Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 31 India Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 32 India Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 33 Australia Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 34 Australia Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 35 South Korea Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 36 South Korea Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 37 Latin America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 38 Latin America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 39 Brazil Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 40 Brazil Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 41 Mexico Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 42 Mexico Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 43 Rest of Latin America Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 44 Rest of Latin America Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 45 Middle East and Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 46 Middle East and Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 47 GCC Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 48 GCC Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 49 Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 50 Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)
• TABLE 51 Rest of Middle East and Africa Nucleic Acid Testing Market By Technology, 2020-2030, USD (Million)
• TABLE 52 Rest of Middle East and Africa Nucleic Acid Testing Market By Applications, 2020-2030, USD (Million)

List of Figures

• FIG. 1 Global Nucleic Acid Testing Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Nucleic Acid Testing Market: Quality Assurance
• FIG. 5 Global Nucleic Acid Testing Market, By Technology, 2021
• FIG. 6 Global Nucleic Acid Testing Market, By Applications, 2021
• FIG. 7 Global Nucleic Acid Testing Market, By Geography, 2021
• FIG. 8 Market Geographical Opportunity Matrix - Global Nucleic Acid Testing Market, 2021
• FIG. 9 Market Positioning of Key Nucleic Acid Testing Market Players, 2021
• FIG. 10 Global Nucleic Acid Testing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
• FIG. 11 Global Nucleic Acid Testing Market, By Technology, 2021 Vs 2030, %
• FIG. 12 Global Nucleic Acid Testing Market, By Applications, 2021 Vs 2030, %
• FIG. 13 U.S. Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 14 Canada Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 15 Rest of North America Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 16 UK Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 17 Germany Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 18 Spain Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 19 Italy Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 20 France Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 21 Rest of Europe Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 22 China Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 23 Japan Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 24 India Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 25 Australia Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 26 South Korea Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 27 Rest of Asia Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 28 Brazil Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 29 Mexico Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 30 Rest of Latin America Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 31 GCC Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 32 Africa Nucleic Acid Testing Market (US$ Million), 2020 - 2030
• FIG. 33 Rest of Middle East and Africa Nucleic Acid Testing Market (US$ Million), 2020 - 2030

Factors such as extensive adoption of genetic engineering by research institutes and pharmaceutical companies, technological advancement in diagnostic technique, sensory technology enables the rapid analysis, rising awareness about molecular diagnostic testing driving the market growth of nucleic acid testing globally.

The report titled "Nucleic Acid Testing Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall nucleic acid testing market along with the market size and estimates for the duration of 2020 to 2030. The research study covers in-depth analysis of market segments based on technology, application and different geographical regions.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global nucleic acid testing market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global nucleic acid testing market. This report concludes with company profiles section that highlights major information about the key players engaged in global nucleic acid testing market. In-depth competitive environment analysis and historical years (2021) market size data are also provided in the report.

Nucleic acid testing or nucleic acid amplification testing is generally abbreviated as NAT or NAAT. Variations exist in genome sequences of every individual; that makes NAT an ideal technique for identification of different disorders such as cancer, infectious diseases, genetic disorders, and mitochondrial disorders. Factors such as rapid, sensitive and specific methods compared to the traditional methods of diagnosis is driving the market growth of nucleic acid testing. NAT is widely used to detect and identify organisms for diagnosis, prognosis, and treatment of diseases. Previously NAT was used to screen HIV and HCV virus, however, its application has extended to detect human T-lymph tropic virus, treponema pallidum, hepatitis B virus, west nile virus, plasmodium and trypanosoma. It is observed that, in the base year 2016 infectious diseases held largest market share. NAT is capable of identifying genotypes and subtypes, determining resistance to particular antibiotics, and identifying viral load. All these factors are influencing the market growth of infectious disease segment. Some unique factors such as identification of fastidious bacteria, bacterial resistance testing, determination of bacterial infection after antibiotics are increasing the demand for NAT in identification of infectious disease. In recent years, NAT extensively used for early diagnosis of genetic variations and prevention of cancer. It is estimated that, NAT will play an important role in personalized and predictive medicine in future to avoid adverse reaction of medicines.

Nucleic acid test (NAT) is also known as nucleic acid amplification test (NAAT), is molecular technique used as screening method to detect genetic material such as DNA or RNA. NAT can detect pathogens, it is capable of detecting infectious donations faster than current tests because it detects genetic material rather than antigens or antibodies. Due to its accuracy and specificity demand for nucleic acid testing has increased in recent years. Sample extraction, amplification and target amplicon detection are the major process involved in NAT. Nucleic acid amplification perform by using three methods such as target amplification systems, probe amplification systems and signal amplification. It is observed that target amplification methods such as polymerase chain reaction, strand displacement amplification, ligase chain reaction and transcription-mediated amplification are most widely used in market. In the base year 2021, polymerase chain reaction was observed as the largest revenue generating segment as it is lower cost technique play fundamental role in disease detection, cloning, DNA typing, structural analysis, sequencing, mutation analysis and mapping.

Nucleic acid testing is technique that involves amplification and detection of genetic material such as DNA or RNA. Variations exist in genome sequences of every individual, it makes NAT an ideal technique for detection of different disorder, prenatal screening and carrier screening. Technological advances in diagnostic method, increase in prevalence of infectious and genetic disease are driving the growth of NAT market. It is observed that NAT is widely accepted diagnostic technique in developed countries. Currently, NAT has been adopted in several countries such as Canada, France, Australia, New Zealand, South Africa, and other countries in Europe and Asia. In base year 2021, North America was largest contributor in global nucleic acid testing market and occupied a significant portion of the global market. United States observed as largest revenue generating market in North America. Factors such as technological advancement, extensive adoption of genetic engineering and higher investment in R&D activities driving the market growth of NAT in North America. Asia Pacific is anticipated to show fastest growth rate during forecast period. Factors such as improving economic condition, populous countries and increasing demand of NAT would drive the market growth in Asia Pacific region during forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Nucleic Acid Testing market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nucleic Acid Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Technology

Polymerase chain reaction (PCR)

Strand Displacement Amplification (SDA)

Trocar Ligase chain reaction (LCR)

Transcription-mediated amplification (TMA)

Other

Applications

Infectious Disease

Genetic Disorders

Cancer

Forensic Testing

Other

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Nucleic Acid Testing market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Nucleic Acid Testing market?

Which is the largest regional market for Nucleic Acid Testing market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Nucleic Acid Testing market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Nucleic Acid Testing market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Nucleic Acid Testing Market
• 2.2. Global Nucleic Acid Testing Market, By Technology, 2021 (US$ Million)
• 2.3. Global Nucleic Acid Testing Market, By Applications, 2021 (US$ Million)
• 2.4. Global Nucleic Acid Testing Market, By Geography, 2021 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2021

3. Nucleic Acid Testing Market: Competitive Analysis

• 3.1. Market Positioning of Key Nucleic Acid Testing Market Vendors
• 3.2. Strategies Adopted by Nucleic Acid Testing Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2021 Versus 2030

4. Nucleic Acid Testing Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Nucleic Acid Testing Market Value, 2020 - 2030, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis

5. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2021 Versus 2030
• 5.3. Market Segmentation
  • 5.3.1. Polymerase chain reaction (PCR)
  • 5.3.2. Strand Displacement Amplification (SDA)
  • 5.3.3. Trocar Ligase chain reaction (LCR)
  • 5.3.4. Transcription-mediated amplification (TMA)
  • 5.3.5. Other

6. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2021 Versus 2030
• 6.3. Market Segmentation
  • 6.3.1. Infectious Disease
  • 6.3.2. Genetic Disorders
  • 6.3.3. Cancer
  • 6.3.4. Forensic Testing
  • 6.3.5. Other

7. North America Nucleic Acid Testing Market, 2020-2030, USD (Million)

• 7.1. Market Overview
• 7.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
• 7.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
• 7.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 7.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 7.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 7.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

8. UK and European Union Nucleic Acid Testing Market, 2020-2030, USD (Million)

• 8.1. Market Overview
• 8.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
• 8.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
• 8.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.4.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.5.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 8.4.1.6.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

9. Asia Pacific Nucleic Acid Testing Market, 2020-2030, USD (Million)

• 9.1. Market Overview
• 9.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
• 9.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
• 9.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.4.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.5.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 9.4.1.6.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

10. Latin America Nucleic Acid Testing Market, 2020-2030, USD (Million)

• 10.1. Market Overview
• 10.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
• 10.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
• 10.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 10.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 10.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 10.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

11. Middle East and Africa Nucleic Acid Testing Market, 2020-2030, USD (Million)

• 11.1. Market Overview
• 11.2. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
• 11.3. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
• 11.4.Nucleic Acid Testing Market: By Region, 2020-2030, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 11.4.1.1.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 11.4.1.2.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. Nucleic Acid Testing Market: By Technology, 2020-2030, USD (Million)
      • 11.4.1.3.1. Nucleic Acid Testing Market: By Applications, 2020-2030, USD (Million)

12. Company Profile

• 12.1. Automatic Liquid Packaging Solutions, Llc.
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Catalent, Inc.
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. HealthStar, Inc.
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Hunan Chinasun Pharmaceutical Machinery Co., Ltd.
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Mahanagar Engineering Pvt. Ltd.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. Pharmapack Co., Ltd.
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Rommelag Inc.
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. Shanghai Pharmaceutical Machinery Co., Ltd.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Shanghai Sunway International Trade Co., Ltd.
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives
• 12.10. Truking Technology Ltd.
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Portfolio
  • 12.10.4. Strategic Initiatives
• 12.11. Unither
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Portfolio
  • 12.11.4. Strategic Initiatives
• 12.12. Weiler Engineering, Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Portfolio
  • 12.12.4. Strategic Initiatives